Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 6/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.37 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28064168 | 0.91 | SERPINE1 (0.57) | SERPINE1PTPN1PTPN2PTPN11PRKCA | |
| SCHEMBL20530411 | 0.91 | SERPINE1 (0.57) | SERPINE1PTPN1PTPN2PTPN11PRKCA | |
| SCHEMBL28456939 | 0.90 | SERPINE1 (0.56) | SERPINE1PTPN1PTPN2PTPN11PRKCA | |
| SCHEMBL15303745 | 0.85 | SERPINE1 (0.58) | SERPINE1PTPN1PTPN2PTPN11PRKCA | |
| SCHEMBL28219841 | 0.84 | SERPINE1 (0.57) | SERPINE1PTPN1PTPN2PTPN11PRKCA | |
| SCHEMBL3982817 | 0.84 | SERPINE1 (0.57) | SERPINE1PTPN1PTPN2PTPN11PRKCA | |
| SCHEMBL28031026 | 0.81 | SERPINE1 (0.57) | SERPINE1PTPN1PTPN2PTPN11ESR1 | |
| SCHEMBL391922 | 0.81 | SERPINE1 (0.57) | SERPINE1PTPN1PTPN2PTPN11ESR1 | |
| Water SCHEMBL23067557 | 0.80 | SERPINE1 (0.56) | SERPINE1PTPN1PTPN2PTPN11ESR1 | |
| SCHEMBL5664340 | 0.80 | SERPINE1 (0.44) | SERPINE1PTPN1PTPN2PTPN11PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110833560-B | Application of 2,4, 6-tri-O-galloyl-D-glucose in decocting of Chinese herbal medicines in preparation of antitumor medicines | 河南中医药大学 | 2022-09-16 | — | — | CN | claimed |
| CN-110833560-A | Application of 2,4, 6-tri-O-galloyl-D-glucose in decocting of Chinese herbal medicines in preparation of antitumor medicines | 河南中医药大学 | 2020-02-25 | — | — | CN | claimed |
| WO-2018216835-A1 | COMPOSITION FOR SKIN WHITENING OR FOR PREVENTING AND ALLEVIATING SKIN HYPERPIGMENTATION DISORDER COMPRISING COMPOUND ISOLATED FROM SEDUM TAKESIMENSE AS EFFECTIVE INGREDIENT | DYNE SOZE CO., LTD (KR) | 2018-11-29 | — | — | WO | claimed |
| US-20040247698-A1 | Erectile Dysfunction Treatment | VALENZUELA CORTES CARMEN MARIA (CL) | 2004-12-09 | — | — | US | claimed |
| CN-110833560-B | Application of 2,4, 6-tri-O-galloyl-D-glucose in decocting of Chinese herbal medicines in preparation of antitumor medicines | 河南中医药大学 | 2022-09-16 | — | — | CN | disclosed |
| CN-110833560-B | Application of 2,4, 6-tri-O-galloyl-D-glucose in decocting of Chinese herbal medicines in preparation of antitumor medicines | 河南中医药大学 | 2022-09-16 | — | — | CN | disclosed |
| CN-110833560-B | Application of 2,4, 6-tri-O-galloyl-D-glucose in decocting of Chinese herbal medicines in preparation of antitumor medicines | 河南中医药大学 | 2022-09-16 | — | — | CN | disclosed |
| CN-110833560-A | Application of 2,4, 6-tri-O-galloyl-D-glucose in decocting of Chinese herbal medicines in preparation of antitumor medicines | 河南中医药大学 | 2020-02-25 | — | — | CN | disclosed |
| CN-110833560-A | Application of 2,4, 6-tri-O-galloyl-D-glucose in decocting of Chinese herbal medicines in preparation of antitumor medicines | 河南中医药大学 | 2020-02-25 | — | — | CN | disclosed |
| CN-110833560-A | Application of 2,4, 6-tri-O-galloyl-D-glucose in decocting of Chinese herbal medicines in preparation of antitumor medicines | 河南中医药大学 | 2020-02-25 | — | — | CN | disclosed |
| WO-2018216835-A1 | COMPOSITION FOR SKIN WHITENING OR FOR PREVENTING AND ALLEVIATING SKIN HYPERPIGMENTATION DISORDER COMPRISING COMPOUND ISOLATED FROM SEDUM TAKESIMENSE AS EFFECTIVE INGREDIENT | DYNE SOZE CO., LTD (KR) | 2018-11-29 | — | — | WO | disclosed |
| WO-2018216835-A1 | COMPOSITION FOR SKIN WHITENING OR FOR PREVENTING AND ALLEVIATING SKIN HYPERPIGMENTATION DISORDER COMPRISING COMPOUND ISOLATED FROM SEDUM TAKESIMENSE AS EFFECTIVE INGREDIENT | DYNE SOZE CO., LTD (KR) | 2018-11-29 | — | — | WO | disclosed |
| US-20180235904-A1 | CANNABIDIOL COMPOSITIONS INCLUDING MIXTURES AND USES THEREOF | EARTH SCIENCE TECH, INC. (US) | 2018-08-23 | — | — | US | disclosed |
| CN-106635840-A | Aspergillus niger strain, preparation method and application of new component generated by fermenting a plurality of medicines and decocting | 河南中医药大学 | 2017-05-10 | — | — | CN | disclosed |
| US-20040247698-A1 | Erectile Dysfunction Treatment | VALENZUELA CORTES CARMEN MARIA (CL) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180235904-A1 | CANNABIDIOL COMPOSITIONS INCLUDING MIXTURES AND USES THEREOF | SQLE, RORB, PHKG2 | SERPINE1 3574/4885PTPN1 4805/4885PTPN2 4737/4885 |
| US-20040247698-A1 | Erectile Dysfunction Treatment | PDE3A, PDE3B, PDE12 | SERPINE1 921/4885PTPN1 4661/4885PTPN2 4501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.